Skip to main content Skip to main navigation menu Skip to site footer

Subacute thyroiditis associated with COVID-19 affecting health professionals, a case series in high-risk population

  • Hendra Zufry ,
  • Sarah Firdausa ,
  • Agustia Sukri Ekadamayanti ,
  • Krishna Wardana Sucipto ,


Background: Healthcare professionals are more vulnerable to infectious infections, especially ones that are easily transferred, such as COVID-19. Subacute thyroiditis is a self-limiting thyroid gland infection caused by a virus. SARS-CoV-2 infection increases the prevalence of subacute thyroiditis.

Objective: This case series addresses the emergence of subacute thyroiditis cases linked to SARS-CoV-2 infection, which is more common in healthcare personnel.

Methods: This study analyzed nine COVID-19 cases with neck pain symptoms. The clinical presentation, thyroid markers, ultrasound features of the thyroid gland, and its management were described in this study.

Result: There were nine cases included, and seven out of nine were experienced by healthcare professional workers. All of them were patients in the Clinic of Endocrinology Metabolism and Diabetes - Thyroid Center, Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia, from January to June 2021. Most of them presented with mild to moderate neck pain. All patients had clinical improvement within two weeks to two months after receiving treatments.

Conclusion: Subacute thyroiditis is a painful thyroid gland disease characterized by acute inflammation of the thyroid gland, which can arise during or after a viral infection such as COVID-19. This case series emphasizes the importance of physicians awareness that subacute thyroiditis could be one of many clinical spectra of SARS-CoV-2 infection that should not be missed.


  1. Ran L, Chen X, Wang Y, Wu W, Zhang L, Tan X. Risk Factors of Healthcare Workers With Coronavirus Disease 2019: A Retrospective Cohort Study in a Designated Hospital of Wuhan in China. Clin Infect Dis. 2020;71(16):2218–21. Available from:
  2. Guven M. Subacute Thyroiditis in the Course of Coronavirus Disease 2019: A Case Report. J Endocrinol Metab. 2020;10(3–4):110–2. Available from:
  3. Dimos G, Pappas G, Akritidis N. Subacute thyroiditis in the course of novel H1N1 influenza infection. Endocrine. 2010;37(3):440–1. Available from:
  4. Nienhaus A, Hod R. COVID-19 among Health Workers in Germany and Malaysia. Int J Environ Res Public Health. 2020;17(13):4881. Available from:
  5. Bellastella G, Maiorino MI, Esposito K. Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands? J Endocrinol Invest. 2020/06/01. 2020;43(8):1169–70. Available from:
  6. Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord. 2020/11/25. 2021;22(4):803–15. Available from:
  7. Ruggeri RM, Campennì A, Siracusa M, Frazzetto G, Gullo D. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones (Athens). 2020/07/16. 2021;20(1):219–21. Available from:
  8. Campos-Barrera E, Alvarez-Cisneros T, Davalos-Fuentes M. Subacute Thyroiditis Associated with COVID-19. Case Rep Endocrinol. 2020;2020:8891539. Available from:
  9. Brancatella A, Ricci D, Cappellani D, Viola N, Sgrò D, Santini F, et al. Is Subacute Thyroiditis an Underestimated Manifestation of SARS-CoV-2 Infection? Insights From a Case Series. J Clin Endocrinol Metab. 2020;105(10):dgaa537. Available from:
  10. Ippolito S, Dentali F, Tanda ML. SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J Endocrinol Invest. 2020/06/02. 2020;43(8):1171–2. Available from:
  11. Mattar SAM, Koh SJQ, Rama Chandran S, Cherng BPZ. Subacute thyroiditis associated with COVID-19. BMJ Case Rep. 2020;13(8):e237336. Available from:
  12. Sohrabpour S, Heidari F, Karimi E, Ansari R, Tajdini A, Heidari F. Subacute Thyroiditis in COVID-19 Patients. Eur Thyroid J. 2020/10/30. 2021;9(6):321–3. Available from:
  13. Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020;24(1):422. Available from:
  14. Rotondi M, Coperchini F, Ricci G, Denegri M, Croce L, Ngnitejeu ST, et al. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest. 2020/10/06. 2021;44(5):1085–90. Available from:
  15. Sharma R, Weerakkody Y. De Quervain thyroiditis. In:; 2014. Available from:
  16. Cappelli C, Pirola I, Gandossi E, Formenti AM, Agosti B, Castellano M. Ultrasound findings of subacute thyroiditis: a single institution retrospective review. Acta radiol. 2014;55(4):429–33. Available from:

How to Cite

Zufry, H. ., Firdausa, S., Ekadamayanti, A. S. ., & Sucipto, K. W. . (2022). Subacute thyroiditis associated with COVID-19 affecting health professionals, a case series in high-risk population. Bali Medical Journal, 12(1), 77–81.




Search Panel

Hendra Zufry
Google Scholar
BMJ Journal

Sarah Firdausa
Google Scholar
BMJ Journal

Agustia Sukri Ekadamayanti
Google Scholar
BMJ Journal

Krishna Wardana Sucipto
Google Scholar
BMJ Journal